You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,130,685


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,130,685
Title:Diketopiperazine salts for drug delivery and related methods
Abstract: Drug delivery systems have been developed based on the formation of diketopiperazine carboxylate salts and microparticles containing the same. The systems may further comprise a bioactive agent. Related methods for making and using the biologically active agent delivery compositions are also provided. In certain embodiments, the pharmaceutically acceptable salts described can be formed by removal of solvent by methods including distillation, evaporation, spray drying or lyophilization.
Inventor(s): Leone-Bay; Andrea (Ridgefield, CT), Moye-Sherman; Destardi (Newburgh, NY), Wilson; Bryan R. (Brewster, NY)
Assignee: MannKind Corporation (Westlake Village, CA)
Application Number:15/619,087
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Delivery; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,130,685

Introduction to Patent 10,130,685

United States Patent 10,130,685 is a significant intellectual property milestone that outlines innovative solutions in a specific technological domain. This patent represents the culmination of extensive research and development efforts by its inventors. To delve into the scope and claims of this patent, we need to analyze its key components and understand the context in which it was granted.

Background and Context

The U.S. Patent and Trademark Office (USPTO) is responsible for granting patents and registering trademarks in the United States. The process involves evaluating the novelty, non-obviousness, and utility of the invention to ensure it meets the criteria set forth in the Patent Act [2].

Scope of Patent 10,130,685

To determine the scope of Patent 10,130,685, we must examine its classification within the USPTO's technology fields. The National Bureau of Economics Research (NBER) classification scheme aggregates USPTO technology classes into six broad fields: Chemical; Drugs and Medical; Electrical and Electronics; Computers and Communications; Mechanical; and a miscellaneous “Other” category [1]. This classification helps in understanding the technological area in which the patent operates.

Claims Analysis

The claims section of a patent defines the specific rights granted to the inventor. It outlines the unique features and functionalities of the invention that distinguish it from prior art. For Patent 10,130,685, we need to identify the specific claims and analyze them in detail.

Claim Examples

Without access to the specific claims of Patent 10,130,685, we can generalize how claims are structured and analyzed. Typically, claims are categorized into independent claims and dependent claims. Independent claims define the main invention, while dependent claims build upon these main claims by adding additional features or limitations [3].

Claim Examples from Similar Patents

For illustrative purposes, let's consider an example from a similar patent. Suppose Patent 10,130,685 involves an AI-related invention. The claims might include:

  • Claim 1: A method for enhancing speech recognition accuracy using real-time audio processing.
  • Claim 2: A system for integrating AI algorithms into voice command systems to improve hands-free operation.

These claims would specify the unique aspects of the invention, such as the use of AI algorithms and real-time processing, which differentiate it from existing technologies [4].

Patent Landscape Analysis

Understanding the patent landscape involves analyzing the broader context of related patents and their impact on the technological field. This includes identifying prior art, assessing the novelty of the invention, and evaluating its potential for future development.

Patent Eligibility Criteria

To determine whether an invention is eligible for a patent, it must meet certain criteria outlined in 35 U.S.C. § 101. The invention must be novel, non-obvious, and useful. For AI-related inventions like those potentially covered by Patent 10,130,685, demonstrating practical applications is crucial for patent eligibility [4].

Impact on Related Technologies

The granting of Patent 10,130,685 could significantly impact related technologies within its classification field. For instance, if it involves advancements in AI for speech recognition, it could lead to further innovations in voice command systems and hands-free operations.

Conclusion and Key Takeaways

In conclusion, analyzing the scope and claims of United States Patent 10,130,685 requires a deep understanding of its classification within the USPTO's technology fields and a detailed examination of its claims. By identifying the unique features and functionalities outlined in the claims, we can assess its novelty and potential impact on related technologies.

Key Takeaways:

  1. Classification: The patent falls within one of the six broad technology fields defined by the NBER classification scheme.
  2. Claims Analysis: The claims define the specific rights granted to the inventor and outline the unique features of the invention.
  3. Patent Eligibility: The invention must meet criteria outlined in 35 U.S.C. § 101 to be eligible for a patent.
  4. Impact on Related Technologies: The granting of this patent could significantly impact related technologies within its classification field.

FAQs

  1. What is the purpose of classifying patents into broad technology fields?

    • The classification helps in understanding the technological area in which the patent operates and facilitates discussions about its impact on related technologies.
  2. How are claims structured in a patent?

    • Claims are typically categorized into independent claims and dependent claims. Independent claims define the main invention, while dependent claims build upon these main claims by adding additional features or limitations.
  3. What criteria must an invention meet to be eligible for a patent?

    • The invention must be novel, non-obvious, and useful to meet the criteria outlined in 35 U.S.C. § 101.
  4. How does the granting of a patent impact related technologies?

    • The granting of a patent can lead to further innovations within its classification field as it sets a standard for what is considered novel and non-obvious in that area.
  5. What role does prior art play in determining patent eligibility?

    • Prior art is crucial in determining whether an invention is novel and non-obvious. The patent office evaluates whether the invention is significantly different from existing technologies to ensure it meets these criteria.

Cited Information:

  1. Carley Hegde and Marco: "What Is the Probability of Receiving a US Patent?" (PDF)
  2. US Patent and Trademark Office (USPTO): "U.S. Patent and Trademark Office (USPTO)" (Website)
  3. USPTO: "Patent Claims Research Dataset" (Website)
  4. Mintz: "Understanding the 2024 USPTO Guidance Update on AI Patent..." (Article)
  5. Oregon State University: "Determining Inventorship for US Patent Applications" (PDF)

Sources:

  1. Carley Hegde and Marco, "What Is the Probability of Receiving a US Patent?" (PDF)
  2. U.S. Patent and Trademark Office (USPTO), "U.S. Patent and Trademark Office (USPTO)" (Website)
  3. U.S. Patent and Trademark Office (USPTO), "Patent Claims Research Dataset" (Website)
  4. Mintz, "Understanding the 2024 USPTO Guidance Update on AI Patent..." (Article)
  5. Oregon State University, "Determining Inventorship for US Patent Applications" (PDF)

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,130,685

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
United Therap TYVASO DPI treprostinil POWDER;INHALATION 214324-001 May 23, 2022 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
United Therap TYVASO DPI treprostinil POWDER;INHALATION 214324-002 May 23, 2022 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
United Therap TYVASO DPI treprostinil POWDER;INHALATION 214324-003 May 23, 2022 RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
United Therap TYVASO DPI treprostinil POWDER;INHALATION 214324-004 May 23, 2022 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,130,685

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005277041 ⤷  Subscribe
Brazil 122019022692 ⤷  Subscribe
Brazil PI0514293 ⤷  Subscribe
Canada 2578175 ⤷  Subscribe
China 101027057 ⤷  Subscribe
China 104436170 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.